TABLE 2.
Performance test characteristics of the febrile respiratory illness (FRI) and influenza-like illness (ILI) infection screening tools in primary and secondary analysis groups
Positive, n | Negative, n | % (95% CI) | Predictive value | Likelihood ratio, % (95% CI) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
True | False | True | False | Sensitivity | Specificity | Positive | Negative | Positive | Negative | |
Laboratory-confirmed influenza (n=200) | ||||||||||
FRI | 35 | 103 | 50 | 12 | 74.5 (60.5–84.8) | 32.7 (25.8–40.5) | 25.4 | 80.6 | 1.1 (0.92–1.36) | 0.78 (0.45–1.32) |
ILI* | 34 | 73 | 63 | 11 | 75.6 (61.3–85.8) | 46.3 (38.2–54.7) | 31.8 | 85.1 | 1.4 (1.12–1.77) | 0.53 (0.31–0.91) |
Clinical diagnosis of influenza (n=391) | ||||||||||
FRI | 39 | 131 | 206 | 15 | 72.2 (59.1–82.3) | 61.1 (55.8–66.1) | 22.9 | 93.2 | 1.9 (1.50–2.30) | 0.45 (0.29–0.70) |
ILI* | 38 | 87 | 229 | 14 | 73.1 (59.8–83.2) | 72.4 (67.3–77.1) | 30.4 | 94.2 | 2.7 (2.08–3.39) | 0.37 (0.24–0.58) |
Total numbers in the ILI groups were fewer because all participants with a FRI did not have an ILI screen completed